333 related articles for article (PubMed ID: 25637592)
1. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
[TBL] [Abstract][Full Text] [Related]
2. Discontinuing Cancer Screening for Older Adults: a Comparison of Clinician Decision-Making for Breast, Colorectal, and Prostate Cancer Screenings.
Enns JP; Pollack CE; Boyd CM; Massare J; Schoenborn NL
J Gen Intern Med; 2022 Apr; 37(5):1122-1128. PubMed ID: 34545468
[TBL] [Abstract][Full Text] [Related]
3. Adult Patients' Perspectives on the Benefits and Harms of Overused Screening Tests: a Qualitative Study.
Sutkowi-Hemstreet A; Vu M; Harris R; Brewer NT; Dolor RJ; Sheridan SL
J Gen Intern Med; 2015 Nov; 30(11):1618-26. PubMed ID: 25869017
[TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
5. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
6. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
7. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Li J; Zhao G; Hall IJ
Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
[TBL] [Abstract][Full Text] [Related]
8. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
Sirovich BE; Schwartz LM; Woloshin S
JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
[TBL] [Abstract][Full Text] [Related]
9. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
10. Decision fatigue in low-value prostate cancer screening.
Hunt TC; Ambrose JP; Haaland B; Kawamoto K; Dechet CB; Lowrance WT; Hanson HA; O'Neil BB
Cancer; 2021 Sep; 127(18):3343-3353. PubMed ID: 34043813
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
12. Patients' and Clinicians' Perceptions of Antibiotic Prescribing for Upper Respiratory Infections in the Acute Care Setting.
Broniatowski DA; Klein EY; May L; Martinez EM; Ware C; Reyna VF
Med Decis Making; 2018 Jul; 38(5):547-561. PubMed ID: 29847253
[TBL] [Abstract][Full Text] [Related]
13. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
Black A; Berg CD
Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
[TBL] [Abstract][Full Text] [Related]
15. PSA in screening for prostate cancer: more good than harm or more harm than good?
Duffy MJ
Adv Clin Chem; 2014; 66():1-23. PubMed ID: 25344984
[TBL] [Abstract][Full Text] [Related]
16. The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior.
McDowell ME; Occhipinti S; Chambers SK
Health Psychol; 2013 Nov; 32(11):1158-69. PubMed ID: 23527518
[TBL] [Abstract][Full Text] [Related]
17. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
18. Clinician Factors Associated With Prostate-Specific Antigen Screening in Older Veterans With Limited Life Expectancy.
Tang VL; Shi Y; Fung K; Tan J; Espaldon R; Sudore R; Wong ML; Walter LC
JAMA Intern Med; 2016 May; 176(5):654-61. PubMed ID: 27042937
[TBL] [Abstract][Full Text] [Related]
19. The influence of physician recommendation on prostate-specific antigen screening.
Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
[TBL] [Abstract][Full Text] [Related]
20. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
